FUROSCIX READYFLOW (AUTOINJECTOR) FDA approval date
The FDA approved FUROSCIX READYFLOW (AUTOINJECTOR) on 7 Oct 2022.
- FDA approval date
- 7 Oct 2022
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as FUROSEMIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2022-10-07Day | FUROSCIX READYFLOW (AUTOINJECTOR) | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209988", "applicant_as_listed_by_fda": "SCPHARMACEUTICALS", "brand_names": ["FUROSCIX", "FUROSCIX READYFLOW (AUTOINJECTOR)"], "active_ingredients": ["FUROSEMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20221007", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |